MiR-526b-3p enhances sensitivity of head and neck squamous cell carcinoma cells to radiotherapy via suppressing exosomal LAMP3-mediated autophagy. 2023

Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, Wuwei, Gansu, China.

Lysosomal associated membrane protein 3 (LAMP3) has been reported to be a tumour promoter in multiple cancer types by modulating tumour cell autophagy. However, the potential mechanism of LAMP3 in radio-resistance of head and neck squamous cell carcinoma (HNSCC) remains unknown. Therefore, our current study aims to detect the impacts of LAMP3 on the resistance of HNSCC cells to radiotherapy and meanwhile explore its functional mechanism. Through RT-Qpcr examination, LAMP3 expression was identified to be expressed at a significantly high level in irradiation-resistant HNSCC cell lines compared with irradiation-sensitive HNSCC cell lines. Functional assays including CCK-8, colony formation and Transwell assays demonstrated that LAMP3 enhanced the radio-resistance through inducing autophagy to promote HNSCC cell growth. Furthermore, irradiation-resistant HNSCC cells could transfer exosomal LAMP3 to elevate LAMP3 expression in irradiation-sensitive HNSCC cells. Mechanistically, microRNA (miRNA) miR-526b-3p could inhibit LAMP3 expression so as to strengthen sensitivity of HNSCC cells to radiotherapy. In a word, exosomal LAMP3 expression promoted radioresistance of HNSCC cells via inducing autophagy, while this effect could be suppressed by miR-526b-3p in a targeted manner.

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077195 Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. HNSCC,Head And Neck Squamous Cell Carcinomas,Hypopharyngeal Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Oral Squamous Cell Carcinomas,Oral Tongue Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma,Squamous Cell Carcinoma of Larynx,Squamous Cell Carcinoma of the Larynx,Squamous Cell Carcinoma of the Mouth,Squamous Cell Carcinoma of the Nasal Cavity,Carcinoma, Squamous Cell of Head and Neck,Head and Neck Squamous Cell Carcinoma,Squamous Cell Carcinoma of the Head and Neck,Squamous Cell Carcinoma, Head And Neck
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D051907 Lysosomal Membrane Proteins Ubiquitously expressed integral membrane glycoproteins found in the LYSOSOME. LAMP Lysosomal-Associated Membrane Protein,LAMP Lysosomal-Associated Membrane Proteins,Lysosomal Integral Membrane Protein,Lysosomal Membrane Glycoprotein,Lysosomal Membrane Protein,Lysosomal-Associated Membrane Protein,Lysosome-Associated Membrane Glycoprotein,Lysosome-Associated Membrane Glycoproteins,Lysosome-Associated Membrane Protein,Lysosomal Integral Membrane Proteins,Lysosomal Membrane Glycoproteins,Lysosomal-Associated Membrane Proteins,Lysosome-Associated Membrane Proteins,LAMP Lysosomal Associated Membrane Protein,LAMP Lysosomal Associated Membrane Proteins,Lysosomal Associated Membrane Protein,Lysosomal Associated Membrane Proteins,Lysosome Associated Membrane Glycoprotein,Lysosome Associated Membrane Glycoproteins,Lysosome Associated Membrane Protein,Lysosome Associated Membrane Proteins,Membrane Glycoprotein, Lysosomal,Membrane Glycoprotein, Lysosome-Associated,Membrane Glycoproteins, Lysosomal,Membrane Glycoproteins, Lysosome-Associated,Membrane Protein, Lysosomal,Membrane Protein, Lysosomal-Associated,Membrane Protein, Lysosome-Associated,Membrane Proteins, Lysosomal,Membrane Proteins, Lysosomal-Associated,Membrane Proteins, Lysosome-Associated
D059666 Lysosomal-Associated Membrane Protein 3 A lysosomal-associated membrane glycoprotein that is expressed at high levels in mature DENDRITIC CELLS. Antigens, CD208,CD208 Antigens,DC-LAMP Protein,LAMP-3 Protein,DC LAMP Protein,LAMP 3 Protein,Lysosomal Associated Membrane Protein 3
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
January 2021, Journal of oncology,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
January 2012, Cancer letters,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
January 2021, Frontiers in oncology,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
April 2024, International dental journal,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
April 1997, Oncogene,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
October 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
September 2021, Head & neck,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
September 2019, Life sciences,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
December 2021, Cell death discovery,
Huixiang Lu, and Junnian Zhou, and Xiaojun Li, and Xiaoqin Han, and Shuping Ma, and Chunlan Feng
August 2017, Oncotarget,
Copied contents to your clipboard!